Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...
Japanese firm Otsuka Pharmaceutical has announced that the company and its UK-based subsidiary Astex Pharmaceuticals are...
BioNTech SE and InstaDeep Ltd. have entered partnership under which BioNTech will acquire InstaDeep to build AI-driven d...
Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...
China-based XtalPi, a pioneering pharmaceutical technology startup powered by artificial intelligence (AI) and automatio...
Japan-based Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company, to discover, ...
The Global Antibiotic Research and Development Partnership (GARDP) and Japanese firm Sumitomo Pharma Co. have signed an ...
The Japanese company Chugai Pharmaceutical Co., Ltd., which owns and operates a fully-owned research center "Chugai Phar...
Japan-based Ono Pharmaceutical has entered a worldwide drug discovery collaboration agreement with Poland's Captor The...
South Korea-based SK Biopharmaceuticals has announced that the state-run Korea Drug Development Fund (KDDF) has decided ...
Japan's Ono Pharmaceutical has entered a drug discovery agreement to discover and develop antibody drugs in the immuno...
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...
On September 19, HUAWEI CONNECT 2022 kicked off in Bangkok, Thailand. At the event, Ken Hu, Rotating and Actin...
Innovent Biologics and Sanofi have announced a collaboration to bring innovative medicines to patients in China with dif...
Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...
With multi drug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments a...
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceuti...
Japan-based startup Elix, Inc., an artificial intelligenet (AI) drug discovery company with the mission of “Rethin...
GlaxoSmithKline (GSK) Singapore has announced that Health Sciences Authority has approved Zejula&nbs...
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...
South Korean startup ILIAS Biologics has signed a Memorandum of Understanding (MoU) with HK inno.N for joint research to...
Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Merck Kore...
Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...
Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...
Japan-based Fujitsu and RIKEN have launched a joint research project on next-generation IT drug discovery technology uti...
The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaboration for co-...
Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...
TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...
Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...
RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...
Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...
Singapore-based SCG Cell Therapy Pte Ltd, a leading biotechnology company, announced that the China National Medic...
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...
Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...
China-based Junshi Biosciences has established a joint venture with Immorna to develop and commercialize new drugs for t...
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...
South Korean firm Celltrion Group has announced new results from an in vivo efficacy study showing that regdan...
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...
Japan headquartered Sosei Group Corporation, the world leader in GPCR-focused structure-based drug design...
VICO Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating t...
Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment f...
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bact...
Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...
UK-based Aptamer Group, the developer of diagnostic and therapeutic Optimer reagents, has signed an agreement with the m...
Sosei Group Corporation has been notified by Pfizer that the first subject in a clinical trial has been dosed with a new...
Shineco, Inc., a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, has annou...
South Korea's Pharmcadd Co. Ltd., a developer of artificial intelligence (AI) and physics-based drug discovery platform,...
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...
Pureos Bioventures announces the final closing of its first fund BB Pureos Bioventures LP (Pureos) with a committed...
The inherent heterogeneity of diseases such as cancer is driving the field of personalized (precision) therapies. Within...
Hitachi, Ltd. and Axcelead, Inc. have announced that they have agreed on a comprehensive collaborative partnership to de...
Shanghai Genechem Co., Ltd., a discovery company dedicated to novel drug target discovery and development of novel thera...
Four months after raising its seed round from Hoxton Ventures and dRX Capital, a venture arm of Novartis Pharma AG, ...
A global leading biotech company GenScript Biotech Corporation has announced that the Company has entered into a strateg...
PerkinElmer, Inc., has announced that its Signals ™ computing platform for documentation, workflow ...
Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...
German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...
QBiotics Group Limited, a Brisbane (Australia) life sciences company developing novel anticancer and wound healing pharm...
Boehringer Ingelheim and Gubra on March, 1st 2021 announced a new research and licensing agreement focused on ...
Chinese firm HitGen has announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to ...
China based Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug disco...
AI-assisted computing has greatly improved the efficiency of new drug research and development. China's Suntrap Life Tec...
Since the previous century, Tropical and subtropical regions have been grappling under the parasitic...
Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...
Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...
Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...
